Catalyst Wire Dossier Catalyst Wire Dossier

Nulojix

belatacept · Bristol-Myers Squibb
Drug timelines are a Plus or Pro feature.

28 regulatory and trial events tracked for Nulojix, covering 2011-06-15 to 2026-04-23. Get the full timeline:

Most recent: EMA Authorised: Nulojix (belatacept) — Bristol-Myers Squibb Pharma EEIG

See pricing